Evidence map›Paper›PMID 33282496›Full record

ArticleBiomedical optics express2020

Polarization sensitive optical coherence tomography for imaging microvascular information within living tissue without polarization-induced artifacts.

Peijun Tang, Ruikang K Wang

Abstract read
In one paragraph

Article in Biomedical optics express, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Peijun TangDepartment of Bioengineering, University of Washington, 3720 15th Avenue NE, Seattle, WA 98195, USA.
Ruikang K WangDepartment of Bioengineering, University of Washington, 3720 15th Avenue NE, Seattle, WA 98195, USA.ORCID https://orcid.org/0000-0001-5169-8822

Funding

Perfusable 3D human cardiac constructs for heart regenerationR01HL141570 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E, ZHENG, YING · 2018 to 2021
$3.3M
NHLBI NIH HHS R01 HL141570
6 · The paper itself

Abstract

When imaging birefringent samples using optical coherence tomography angiography (OCTA), the phase retardation may appear opposite to the phase change due to the blood flow in the orthogonal signals, for which a cancellation effect can occur when deriving OCTA signals. This effect can diminish the ability of OCTA to detect vascular information, leading to an erroneous interpretation of the final OCTA images. To mitigate this issue, we demonstrate polarization-sensitive optical coherence tomography (PS-OCT) to image microvascular information within a living sample without polarization induced artifacts. The system is furnished with a swept source OCT (SS-OCT) that incorporates two imaging modes: OCTA imaging and polarization-sensitive imaging. PS-OCT is used to provide birefringent contrast where the color-encoded Stokes parameters are used to obtain high contrast polarization-state images. OCTA is used to acquire high-resolution images of functional microvascular networks permeating the scanned tissue volume. Taking the advantages of the dual-channel PS-OCT configuration, the polarization induced artifacts are eliminated from OCTA vascular imaging. The proposed PS-OCTA system is employed to visualize the birefringent components and the vascular networks of the human skin in vivo. It is expected that the proposed system setup would have useful and practical applications in the investigations of the vasculature in the birefringent tissue samples both pre-clinically and clinically.

Identifiers

PMID33282496
PMCPMC7687965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.